DOCETAXEL RETREATMENT IN DOCETAXEL-PRETREATED CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Di Lorenzo, Giuseppe [1 ]
Palmieri, Giovannella [1 ]
Buonerba, Carlo [1 ]
Marinelli, Alfredo [1 ]
De Placido, Sabino [1 ]
Altieri, Vincenzo [2 ]
Ferro, Matteo [2 ]
Mariano, Marsicano [2 ]
Vittorino, Montanaro [2 ]
Luigi, Castaldo [2 ]
Antonio, Tesone [2 ]
Modestino, Tronino [2 ]
机构：
[1] Univ Naples Federico 2, Dipartimento Endocrinol & Oncol Clin & Molecolare, I-80100 Naples, Italy
[2] Univ Naples Federico 2, Inst Urol, Dipartimento Scienze Ostetr Ginecolog Urolog & Me, I-80100 Naples, Italy
来源：
ANTICANCER RESEARCH | 2010年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
273
引用
收藏
页码：1533 / 1533
页数：1
相关论文
共 50 条
  • [1] Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer
    Di Lorenzo, Giuseppe
    Buonerba, Carlo
    Faiella, Adriana
    Rescigno, Pasquale
    Rizzo, Mimma
    Autorino, Riccardo
    Perdona, Sisto
    Riccardi, Nando
    Scagliorini, Sarah
    Scognamiglio, Florinda
    Masala, Daniele
    Ferro, Matteo
    Palmieri, Giovannella
    Aieta, Michele
    Marinelli, Alfredo
    Altieri, Vincenzo
    De Placido, Sabino
    Carteni, Giacomo
    BJU INTERNATIONAL, 2011, 107 (02) : 234 - 239
  • [2] Clinical Activity of Enzalutamide in Docetaxel-Naive and Docetaxel-Pretreated Patients With Metastatic Castration-Resistant Prostate Cancer
    Nadal, Rosa
    Zhang, Zhe
    Rahman, Hibba
    Schweizer, Michael T.
    Denmeade, Samuel R.
    Paller, Channing J.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Antonarakis, Emmanuel S.
    PROSTATE, 2014, 74 (15): : 1560 - 1568
  • [3] Retreatment with docetaxel in metastatic castration-resistant prostate cancer (CRPC).
    Gernone, A.
    Pagliarulo, A.
    Pagliarulo, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer
    Barroso-Sousa, Romualdo
    da Fonseca, Leonardo Gomes
    Souza, Karla Teixeira
    Ribeiro Chaves, Ana Carolina
    Kann, Ariel Galapo
    de Castro, Gilberto, Jr.
    Dzik, Carlos
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 6
  • [5] Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer
    Romualdo Barroso-Sousa
    Leonardo Gomes da Fonseca
    Karla Teixeira Souza
    Ana Carolina Ribeiro Chaves
    Ariel Galapo Kann
    Gilberto de Castro
    Carlos Dzik
    Medical Oncology, 2015, 32
  • [6] Compassionate use of abiraterone and cabazitaxel. First experiences in docetaxel-pretreated castration-resistant prostate cancer patients
    Heck, M. M.
    Hoeppner, M.
    Horn, T.
    Thalgott, M.
    Gschwend, J. E.
    Retz, M.
    UROLOGE, 2012, 51 (03): : 390 - 397
  • [7] Cabazitaxel in docetaxel-pretreated metastatic castration resistant prostate cancer (mCRPC): Canadian experience.
    Sridhar, Srikala S.
    Winquist, Eric
    Hubay, Stacey
    Assi, Hazem
    Berry, Scott R.
    Stewart, John
    Levesque, Eric
    Aucoin, Nathalie
    Czaykowski, Piotr
    Saad, Fred
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features
    Loriot, Y.
    Massard, C.
    Gross-Goupil, M.
    Di Palma, M.
    Escudier, B.
    Bossi, A.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2009, 20 (04) : 703 - 708
  • [9] Continuing enzalutamide with docetaxel in castration-resistant prostate cancer
    Shiota, Masaki
    LANCET ONCOLOGY, 2022, 23 (11): : 1345 - 1347
  • [10] Dasatinib combined with docetaxel for castration-resistant prostate cancer
    Araujo, John C.
    Mathew, Paul
    Armstrong, Andrew J.
    Braud, Edward L.
    Posadas, Edwin
    Lonberg, Mathew
    Gallick, Gary E.
    Trudel, Geralyn C.
    Paliwal, Prashni
    Agrawal, Shruti
    Logothetis, Christopher J.
    CANCER, 2012, 118 (01) : 63 - 71
12345